Skip to main content

Peer Review reports

From: The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases

Original Submission
19 Apr 2017 Submitted Original manuscript
29 May 2017 Reviewed Reviewer Report - Jann-Yuan Wang
10 Jun 2017 Reviewed Reviewer Report - Rachel Thomson
5 Jul 2017 Author responded Author comments - Kazuma Yagi
Resubmission - Version 2
5 Jul 2017 Submitted Manuscript version 2
7 Jul 2017 Reviewed Reviewer Report - Jann-Yuan Wang
1 Aug 2017 Author responded Author comments - Kazuma Yagi
Resubmission - Version 3
1 Aug 2017 Submitted Manuscript version 3
Publishing
2 Aug 2017 Editorially accepted
9 Aug 2017 Article published 10.1186/s12879-017-2665-5

You can find further information about peer review here.

Back to article page